The adult respiratory distress syndrome after dextran infusion as an antithrombotic agent in free TRAM flap breast reconstruction

Plastic and Reconstructive Surgery

Volumn 103, Issue 6, 1999, Pages 1706-1708

  Hein, Katherine D ^b   Wechsler, Michael E ^b   Schwartzstein, Richard M ^b   Morris, Donald J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DEXTRAN; METHYLPREDNISOLONE SODIUM SUCCINATE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULATION; ARTICLE; BREAST RECONSTRUCTION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

EID: 0032967027     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199905000-00022     Document Type: Article

References (17)

1. Glicksman, A., Ferder, M., Casale, P., et al. 1457 years of microsurgical experience. Plast. Reconstr. Surg. 100: 355, 1997.
2. Ljungstrom, K.-G. The antithrombotic efficacy of dextran. Acta Chir. Scand. Suppl. 543: 26, 1988.
3. Salemark, L., Wieslander, J. B., Dougan, P., et al. Studies of the antithrombotic effects of dexti an 40 following microarterial trauma. Br. J. Plast. Surg. 44: 15, 1991.
4. Salemark, L., Kundsen, F., and Dougan, P. The effect of dextran 40 on patency following severe trauma in small arteries. Br. J. Plast. Surg. 48: 121, 1995.
5. Rothkopf, D. M., Chu, B., Bern, S., et al. The effect of dextran on microvascular thrombosis in an experimental rabbit model. Plast. Reconstr. Surg. 92: 511, 1993.
6. Wolfort, S. F., Angel, M. F., Knight, K. R., et al. The beneficial effect of dextran on anastomotic patency and flap survival in a strongly thrombogenic model. J. Reconstr. Microsurg. 8: 375, 1992.
7. Rutherford, R. B., Jones, D. N., Bergentz, S.-E., et al. The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass. J. Vasc. Surg. 1: 765, 1984.
8. Davies, D. M. A world survey of anticoagulation practice in clinical microvascular surgery. Br. J. Plast. Surg. 35: 96, 1982.
9. Renck, H., Ljungstrom, K.-G., Hedin, H., et al. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. Acta Chir. Scand. 149: 355, 1983.
10. Ljungstrom, K. G., Revenas, B., Smedegard, G. L., et al. Histopathological lung changes in immune complex mediated anaphylactic shock in humans elicited by dextran. Forensic Sci. Int. 38: 251, 1988.
11. Paull, J. A prospective study of dextran-induced anaphylactoid reactions in 5,745 patients. Anaesth. Intensive Care 15: 163, 1987.
12. Gossman, D. E., and Schneider, F. Hapten resistant dextran induced ARDS reaction following intracoronary stent deployment. Cathet. Cardiorvasc. Diagn. 38: 56, 1996.
13. Taylor, M. A., DiBlasi, S. L., Bender, R. M., et al. Adult respiratory distress syndrome complicating intravenous infusion of low-molecular weight dextran. Cathet. Cardiovasc. Diagn. 32: 249, 1994.
14. Kitziger, K. J., Sanders, W. E., and Andrews, C. P. Acute pulmonary edema associated with use of low-molecular weight dextran for prevention of microvascular thrombosis. J. Hand Surg. (Am.) 15: 902, 1990.
15. Marino, P. L. Lung Injury and Pulmonary Edema. In The ICU Book. Philadelphia: Lea and Febiger, 1991. Pp. 296-297.
16. Cooper, J. A. D., Jr., White, D. A., and Matthay, R. A. Drug-induced pulmonary disease: Part 1. Cytotoxic drugs. Am. Rev. Respir. Dis. 133: 321, 1986.
17. Cooper, J. A., Jr., White, D. A., and Matthay, R. A. Drug-induced pulmonary disease: Part 2. Noncytotoxic drugs. Am. Rev. Respir. Dis. 133: 488, 1986.